Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julio D Duarte

Showing results (21-30 of 72) with videos related to

Pageof 8
Sort By:
Journal of Personalized Medicine|December 23, 2022
Patients' Perspectives of Factors That Influence Pharmacogenetic Testing Uptake: Enhancing Patient Counseling and Results DisseminationDiliara Bagautdinova, Christelle Lteif, Elizabeth Eddy, et al.
Pharmacogenomics|April 11, 2025
Implementation of clinical pharmacogenetic testing in medically underserved patients: a narrative reviewBrian E Gawronski, Irina Fofanova, Angel M Miranda, et al.
Expert Review of Clinical Pharmacology|September 29, 2025
Genotype-guided pharmacotherapy: the challenges of integrating pharmacogenomic testing into routine healthcare with a focus on experiences at a single siteLarisa H Cavallari, Emily J Cicali, Madeline Norris, et al.
Clinical Pharmacology and Therapeutics|April 24, 2024
Leveraging QSP Models for MIPD: A Case Study for Warfarin/INRUndine Falkenhagen, Larisa H Cavallari, Julio D Duarte, et al.
Frontiers in Genetics|January 30, 2023
Exploring perceptions, knowledge, and attitudes regarding pharmacogenetic testing in the medically underservedBrian E Gawronski, Emily J Cicali, Caitrin W McDonough, et al.
Cancer Chemotherapy and Pharmacology|November 21, 2025
Severe toxicity following genotype-guided reduced 5-FU dose in a heterozygous DPYD c.2846A>T carrier with stage III anal carcinoma: A case reportMadeline L Norris, David L DeRemer, Julio D Duarte, et al.
Current Problems in Cardiology|July 1, 2024
Omega-3 fatty acids in the treatment of heart failureMatthew Kelling, Michelle Dimza, Alec Bartlett, et al.
Frontiers in Genetics|August 19, 2021
Cox-sMBPLS: An Algorithm for Disease Survival Prediction and Multi-Omics Module Discovery Incorporating <i>Cis</i>-Regulatory Quantitative EffectsNasim Vahabi, Caitrin W McDonough, Ankit A Desai, et al.
Journal of Cardiovascular Pharmacology|January 3, 2020
Beta-Blocker Dose Stratifies Mortality Risk in a Racially Diverse Heart Failure PopulationChristelle Lteif, Meghan J Arwood, Mayank Kansal, et al.
Scientific Reports|December 22, 2019
Transcriptome-wide analysis associates ID2 expression with combined pre- and post-capillary pulmonary hypertensionMeghan J Arwood, Nasim Vahabi, Christelle Lteif, et al.
Pageof 8

Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
Journal of Personalized Medicine|December 23, 2022
Patients' Perspectives of Factors That Influence Pharmacogenetic Testing Uptake: Enhancing Patient Counseling and Results DisseminationDiliara Bagautdinova, Christelle Lteif, Elizabeth Eddy, et al.
Pharmacogenomics|April 11, 2025
Implementation of clinical pharmacogenetic testing in medically underserved patients: a narrative reviewBrian E Gawronski, Irina Fofanova, Angel M Miranda, et al.
Expert Review of Clinical Pharmacology|September 29, 2025
Genotype-guided pharmacotherapy: the challenges of integrating pharmacogenomic testing into routine healthcare with a focus on experiences at a single siteLarisa H Cavallari, Emily J Cicali, Madeline Norris, et al.
Clinical Pharmacology and Therapeutics|April 24, 2024
Leveraging QSP Models for MIPD: A Case Study for Warfarin/INRUndine Falkenhagen, Larisa H Cavallari, Julio D Duarte, et al.
Frontiers in Genetics|January 30, 2023
Exploring perceptions, knowledge, and attitudes regarding pharmacogenetic testing in the medically underservedBrian E Gawronski, Emily J Cicali, Caitrin W McDonough, et al.
Cancer Chemotherapy and Pharmacology|November 21, 2025
Severe toxicity following genotype-guided reduced 5-FU dose in a heterozygous DPYD c.2846A>T carrier with stage III anal carcinoma: A case reportMadeline L Norris, David L DeRemer, Julio D Duarte, et al.
Current Problems in Cardiology|July 1, 2024
Omega-3 fatty acids in the treatment of heart failureMatthew Kelling, Michelle Dimza, Alec Bartlett, et al.
Frontiers in Genetics|August 19, 2021
Cox-sMBPLS: An Algorithm for Disease Survival Prediction and Multi-Omics Module Discovery Incorporating <i>Cis</i>-Regulatory Quantitative EffectsNasim Vahabi, Caitrin W McDonough, Ankit A Desai, et al.
Journal of Cardiovascular Pharmacology|January 3, 2020
Beta-Blocker Dose Stratifies Mortality Risk in a Racially Diverse Heart Failure PopulationChristelle Lteif, Meghan J Arwood, Mayank Kansal, et al.
Scientific Reports|December 22, 2019
Transcriptome-wide analysis associates ID2 expression with combined pre- and post-capillary pulmonary hypertensionMeghan J Arwood, Nasim Vahabi, Christelle Lteif, et al.
Pageof 8